All times listed are Central Time Zone.
| 9:00 AM |
Welcome William Gradishar, MD |
|
SESSION 1
Future Issues in Breast Cancer Session Chair: Nora Hansen, MD | |
| 9:10 AM |
AI in Breast Imaging Linda Moy, MD |
| 9:40 AM |
AI in Pathology Matthew Hanna, MD |
| 10:10 AM |
Minimal Residual Disease: Assessment and Implications Pedram Razavi, MD, PhD |
| 10:40 AM |
Cardiac Issues Related to Breast Cancer RX Nausheen Akhter, MD |
| 11:10 AM |
Q&A |
| 11:40 AM |
Break, Exhibits, and Lunch |
|
SESSION 2
Breast Pathology for the Non-Pathologist Session Chair: Kalliopi Siziopikou, MD, PhD | |
| 1:00 PM |
HER2-Low Breast Cancer: Current Progress and Remaining Challenges Kalliopi Siziopikou, MD, PhD |
| 1:30 PM |
Updates in the Pathology of Pregnancy Associated Breast Cancer Luis Blanco Jr., MD |
| 2:00 PM |
Prognostic and Predictive Factors in Breast Cancer Hannah Wen, MD, PhD |
| 2:30 PM |
Molecular Biomarkers and Genomic Assays in Breast Cancer Virginia Kaklamani, MD, DSc |
| 3:00 PM |
Q&A |
| 3:20 PM |
Break |
| 3:40 PM |
Unusual Cases William Gradishar, MD & confirmed faculty |
| 4:30 PM |
Adjourn Day 1 |
| 4:45 PM |
Opening Reception |
|
View more agendas: Thursday | Friday | Saturday | Sunday | |
|
SESSION 3
Imaging & Risk Session Chair: Seema Khan, MD | |
| 8:30 AM |
Moderate Penetrance Genes: Risk Level and Management Strategies Claudine Isaacs, MD |
| 9:00 AM |
Surgery in Genetically Induced Breast Cancer Seema Khan, MD |
| 9:30 AM |
Genetic Risk Evaluation of Patient and Family Members: Practice vs Promise Steven Katz, MD, MPH |
| 10:00 AM |
Break |
| 10:20 AM |
What’s New in Non-Genetic Risk? Melissa Pilewskie, MD |
| 10:50 AM |
Update Enhanced Contrast Enhanced Mammography Maxine Jochelson, MD |
| 11:20 AM |
Q&A |
| 11:45 AM |
Break, Exhibits, and Lunch |
|
SESSION 4
Triple Negative Breast Cancer (TNBC) and Advanced Diagnosis Session Chair: Swati Kulkarni, MD | |
| 1:10 PM |
Enhancing Adjuvant Therapy of TNBC Hope Rugo, MD |
| 1:40 PM |
Special Subtypes of TNBC Stuart Schnitt, MD |
| 2:10 PM |
Metastatic TNBC Lisa Carey, MD |
| 2:40 PM |
Surgical Issues in Advanced Breast Cancer Audree Tadros, MD, MPH |
| 3:10 PM |
Break |
| 3:30 PM |
Axillary Surgery After Neoadjuvant Therapy Tracy-Ann Moo, MD |
| 4:00 PM |
Q&A |
| 4:30 PM |
Adjourn Day 2 |
|
View more agendas: Thursday | Friday | Saturday | Sunday | |
|
SESSION 5
Management of ER+ Disease Session Chair: William Gradishar, MD | |
| 8:30 AM |
Adjuvant Therapy of ER+ Breast Cancer Kevin Kalinsky, MD, MS |
| 9:00 AM |
SERDs and Beyond Erika Hamilton, MD |
| 9:30 AM |
Infiltrating Lobular Carcinoma Tari King, MD |
| 10:00 AM |
Neoadjuvant Endocrine Therapy Otto Metzger, MD |
| 10:30 AM |
Q&A |
| 11:00 AM |
Break |
| 11:20 AM |
LYNN SAGE DISTINGUISHED LECTURE Breast Cancer: Advances over Three Decades and Future Potential Eric Winer, MD |
| 12:20 PM |
Break, Exhibits, and Lunch |
|
SESSION 6
Controversies in HER2+ Breast Cancer Session Chair: Jonathan Strauss, MD, MBA | |
| 1:30 PM |
Adjuvant/Neoadjuvant Therapy of HER2+ Early Breast Cancer Sarah Tolaney, MD |
| 2:00 PM |
Triple Positive Breast Cancer Sara Hurvitz, MD |
| 2:30 PM |
Sequencing of HER2 Therapy in Metastatic Breast Cancer William Gradishar, MD |
| 3:00 PM |
Management of Oligometastatic Disease Jonathan Strauss, MD, MBA |
| 3:30 PM |
Q&A |
| 4:00 PM |
Case Management Panel Moderator: Monica Morrow, MD |
| 5:15 PM |
Adjourn Day 3 |
|
View more agendas: Thursday | Friday | Saturday | Sunday | |
|
SESSION 7
Unresolved Problems Session Chair: Monica Morrow, MD | |
| 8:30 AM |
Radiation Therapy Scheduling: Which is Best? Julia White, MD |
| 9:00 AM |
Understanding Risk Factors for Lymphedema Development after ALND Andrea Barrio, MD |
| 9:30 AM |
Evolving Role of Axillary Surgery Monica Morrow, MD |
| 10:00 AM |
Lumpectomy Re-Visited 2022 Armando Guiliano, MD |
| 10:30 AM |
Q&A |
| 11:00 AM |
Adjourn Day 4 |
|
View more agendas: Thursday | Friday | Saturday | Sunday | |
The Lurie Cancer Center's Lynn Sage Breast Cancer Symposium offers 3 days of formal presentations and interactive Q&A sessions.
The Lynn Sage Breast Cancer Symposium is proud of its tradition of attracting a faculty comprised of experts from around the world. Faculty list
Optional, non-CME educational activities are scheduled during times that do not conflict with the Symposium agenda.
